Mark E. Parker

No ORCID on file · 1 paper in corpus · active 2009

Study types

  • article 1
article 2009
·doi:10.1159/000215132

3 individuals from 2 unrelated families with recurrent thromboses and quantitative deficiencies of antithrombin III (AT-III) were treated with danazol, 600 mg daily for 4 months. Significant increases of AT-III (p less than 0.025) measured …